Detalhe da pesquisa
1.
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Am J Respir Crit Care Med
; 207(1): 38-49, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926164
2.
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
J Autoimmun
; 140: 103118, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37826919
3.
Validation of questionnaire-reported chest wall abnormalities with a telephone interview in Swiss childhood cancer survivors.
BMC Cancer
; 21(1): 787, 2021 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34238236
4.
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Med
; 4(2): 113-129.e7, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693381
5.
Vitamin C Deficiency in Blood Samples of COVID-19 Patients.
Antioxidants (Basel)
; 11(8)2022 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36009299
6.
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292517
7.
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
Sci Immunol
; 7(75): eabn9644, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054337